Table 5 Avidity of anti-PPS antibodies from young and elderly.
Pre-immune serum GMC (95% CI) | ||||
|---|---|---|---|---|
| Â | Â | CPS | CPS + 22F | P value |
PPS4 | Young | 0.19 (0.07–0.32) | 0.21 (0.04–0.38) | 0.091 |
|  | Elderly | 0.22 (0.13–0.31) | 0.22 (0.12–0.31) | 0.646 |
PPS14 | Young | 0.28 (0.21–0.36) | 0.27 (0.19–0.35) | 0.711 |
|  | Elderly | 0.43 (0.27–0.59) | 0.42 (0.27–0.56) | 0.196 |
Post-immune serum GMC (95% CI) | ||||
| Â | Â | CPS | CPS+22F | P value |
PPS4 | Young | 0.35 (0.22–0.49) | 0.40 (0.25–0.55) | 0.053 |
|  | Elderly | 0.43 (0.23–0.63) | 0.46 (0.26–0.65) | 0.014 |
PPS14 | Young | 0.47 (0.33–0.62) | 0.41 (0.29–0.54) | 0.618 |
|  | Elderly | 0.68 (0.50–0.85) | 0.66 (0.48–0.84) | 0.715 |